Pharmaceutical - Respiratory and Pulmonary, Japan

Filter

Popular Filters

Asthma drug market set to grow $23 billion by 2023

28-11-2014

The asthma treatment market value will grow across eight major countries (the USA, UK, France, Germany,…

AdvairAstraZenecaAustraliaEuropeGlaxoSmithKlineJapanMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySingulairSymbicortUSA

ALK's strategic partner Torii in final stage of clinical development for Japanese cedar allergy

ALK's strategic partner Torii in final stage of clinical development for Japanese cedar allergy

02-09-2014

Japanese drugmaker Torii Pharmaceutical has begun a Phase II/III development program with Denmark-based…

ALK AbelloAllergologyImmunologyJapanMedicinePharmaceuticalResearchRespiratory and PulmonarySLIT-tabletTorii Pharma

GSK’s Anoro Ellipta approved in Japan for COPD

GSK’s Anoro Ellipta approved in Japan for COPD

04-07-2014

UK pharma giant GlaxoSmithKline and US partner Theravance said this morning that the Japanese Ministry…

Anoro ElliptaGlaxoSmithKlineJapanPharmaceuticalRespiratory and PulmonaryTheravance

ALK’s Japanese partner posts mixed results for house dust mite SLIT-tablet

ALK’s Japanese partner posts mixed results for house dust mite SLIT-tablet

16-06-2014

Denmark-based allergy specialist ALK Abello partner for Japan, Torii Pharmaceutical, has completed its…

ALK AbelloJapanPharmaceuticalRegulationResearchRespiratory and PulmonarySLIT-tabletTorii Pharma

Back to top